Disc Medicine, Inc.(IRON)

Biotechnology · Watertown, MA

$62.90-0.43 (-0.68%)

Delayed quote: Oct 6, 2026, 1:35 PM EDT

Disc Medicine (IRON) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:36:58.451Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:36:58.451Z.

Quote observation: 2026-10-06T17:35:11.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 62.9
Unrounded diluted TTM EPS · period ending 2026-06-30: -6.6

FMP input reference: 76fc2c3b696fe1037033af5d10d354cd3b8573abd6cfebee9ff2ae185940ee40

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

IRON PE Ratio Metrics

PE RATIO

N/A

IRON Competitors' PE Ratio

IRON

Disc Medicine, Inc.

Current

Market Cap

$2.41B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SUPN

Supernus Pharmaceuticals, Inc.

vs IRON

Market Cap

$2.42B

PE Ratio

N/A

TTM Avg

32.96

3Y Avg

1828.93

5Y Avg

1067.03

CLOV

Clover Health Investments, Corp.

vs IRON

Market Cap

$2.40B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALMR

Alamar Biosciences, Inc.

vs IRON

Market Cap

$2.39B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RXRX

Recursion Pharmaceuticals, Inc.

vs IRON

Market Cap

$2.37B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADMA

ADMA Biologics, Inc.

vs IRON

Market Cap

$2.36B

PE Ratio

14.52

TTM Avg

17.01

3Y Avg

39.38

5Y Avg

39.38

LQDA

Liquidia Corporation

vs IRON

Market Cap

$2.33B

PE Ratio

19.15

TTM Avg

352.62

3Y Avg

352.62

5Y Avg

352.62

UFPT

UFP Technologies, Inc.

vs IRON

Market Cap

$2.32B

PE Ratio

32.40

TTM Avg

26.95

3Y Avg

32.74

5Y Avg

31.58

NRIX

Nurix Therapeutics, Inc.

vs IRON

Market Cap

$2.32B

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAMS

NewAmsterdam Pharma Company N.V.

vs IRON

Market Cap

$2.53B

PE Ratio

N/A

TTM Avg

76.83

3Y Avg

76.83

5Y Avg

76.83

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Disc Medicine, Inc. (IRON)	$2.41B	N/A	N/A	N/A	N/A
Supernus Pharmaceuticals, Inc. (SUPN)vs ›	$2.42B	N/A	32.96	1828.93	1067.03
Clover Health Investments, Corp. (CLOV)vs ›	$2.40B	N/A	N/A	N/A	N/A
Alamar Biosciences, Inc. (ALMR)vs ›	$2.39B	N/A	N/A	N/A	N/A
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.37B	N/A	N/A	N/A	N/A
ADMA Biologics, Inc. (ADMA)vs ›	$2.36B	14.52	17.01	39.38	39.38
Liquidia Corporation (LQDA)vs ›	$2.33B	19.15	352.62	352.62	352.62
UFP Technologies, Inc. (UFPT)vs ›	$2.32B	32.40	26.95	32.74	31.58
Nurix Therapeutics, Inc. (NRIX)vs ›	$2.32B	N/A	N/A	N/A	N/A
NewAmsterdam Pharma Company N.V. (NAMS)vs ›	$2.53B	N/A	76.83	76.83	76.83

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$62.90

Forward EPS (Est.)

$-6.32

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

IRON PE Ratio Metrics

IRON Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics